"GLP-1 based medicines will have a profound effect on the health of individuals, the manufacturers of these drugs and the broader healthcare system over the next 10 years, in our view
Treatment starts at a low dose and steps up over about four months to the 2.4 mg maintenance dose, which helps your body adjust to side effects like nausea
Visit this link for more information on SLM+
After achieving 20.9% weight loss during a 36-week lead-in period, participants switched to placebo regained 14.0% by week 88
Adults receiving semaglutide had greater improvements in multiple cardiometabolic parameters, including fasting plasma glucose, fasting serum insulin, systolic and diastolic blood pressure, triglycerides, LDL cholesterol and high-sensitivity C-reactive protein compared with placebo